Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

12/10/20 mb Regeneron Mab Cocktail Education
December 10, 2020

From: "Madeline Belk" <madeline.belk@hhsys.org>
Sent: Wednesday, December 9, 2020 6:28:33 PM
Subject: Regeneron Mab Cocktail Education
Casirivimab and imdevimab preparation and storage education

Pharmacists,

We now have the Regeneron monoclonal antibody cocktail (casirivimab and imdevimab). It is very similar to the Eli Lilly product (bamlanivimab) in regards to indication, mechanism, adverse effects, and monitoring. However, the preparation and storage are slightly different. Attached you will find a guidance document regarding these aspects of the medication.

Please reach out if you have any questions.






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved